Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Mirum Pharmaceuticals Inc
MIRM | US
91.49
USD-0.46
-0.50%
MIRM | US
Loading StockChartView...
About Mirum Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
91.49
Open
92.50
High
92.88
Low
90.00
Mirum Pharmaceuticals Inc. a biopharmaceutical company focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of primary sclerosing cholangitis and primary biliary cholangitis in adults. Mirum Pharmaceuticals Inc. was incorporated in 2018 and is headquartered in Foster City California.
View LessMIRM | US
Risk
33.5
Sharpe
2.96
Luna's Score
46/100
Recommendation
Hold
Luna says (MIRM | US)
What's Working
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
What's not Working
Price Below SMA10D
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
29.9%1 month
33.5%3 months
47.5%6 months
45.2%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
39.68
Price to book
8.19
Debt to equity
1.38
Debt to assets
0.48
Ent. to EBITDA
-8.85
Ent. to rev.
7.24
PEG
-
Other Fundamentals
EBITDA
-88.76M
MarketCap
4.36B
MarketCap(USD)
4.36B
Div. yield
-
Op. margin
-31.12
Erngs. growth
-
Rev. growth
107.70
Ret. on equity
-70.98
Short ratio
17.96
Short perc.
17.44
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
9.23
Range1M
12.44
Range3M
24.95
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.62
Price X volume
38.04M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -8.85 | 0.53 | Cheaper |
| Ent. to Revenue | 7.24 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 8.19 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 47.54 | 72.80 | Lower Risk |
| Debt to Equity | 1.38 | -1.23 | Expensive |
| Debt to Assets | 0.48 | 0.25 | Expensive |
| Market Cap | 4.36B | 3.66B | Par |
